secwatch / observer
8-K filed January 23, 2023, 6:59 PM ET ticker TNDM CIK 0001438133
M&A confidence high sentiment neutral materiality 0.75

TANDEM DIABETES CARE INC (TNDM): M&A transaction — Tandem Diabetes completes acquisition of AMF Medical for CHF 70.4M upfront plus earnouts

TANDEM DIABETES CARE INC

item 2.01item 9.01

Key facts

Extracted from this filing and checked against the source text.

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

TANDEM DIABETES CARE INC completed an acquisition involving AMF Medical SA for a previous strategic investment of Swiss Francs ("CHF") 8.0 million paid in the third quarter of 2022, a cash payment of CHF 62.4 million paid at the closing of (closed 2023-01-19).

Action
acquisition
Counterparty
AMF Medical SA
Consideration
a previous strategic investment of Swiss Francs ("CHF") 8.0 million paid in the third quarter of 2022, a cash payment of CHF 62.4 million paid at the closing of
Closing
2023-01-19
Exact text from the filing
e Company entered into a Share Purchase Agreement, dated as of December 10, 2022 (the “Purchase Agreement”), by and among the Company, the Sellers listed on Annex B of the Purchase Agreement (collectively, the “Sellers” and each, individually, a “Seller”) and AMF Medical SA, a corporation organized and existing under the laws of Switzerland (“AMF Medical”).
View on SEC.gov

Browse all m&a transactions →

TANDEM DIABETES CARE INC filing history →

Source: SEC EDGAR
accession 0001438133-23-000008
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.